FEATURED EDITORIAL
Cannabinoids and their innate interaction with the endocannabinoid system, specifically with neuronal functioning, present an attractive therapeutic pathway for Alzheimer's disease, explains Eric Hsu, Ph.D., senior vice president of preclinical research and development at InMed Pharmaceuticals.
- mRNA: The Fourth Pillar Of Pharmaceutical Innovation And Intervention
- Bucking Convention: How Analog Ibogaine Could Help Conquer CNS Disorders
- Innovating Bioequivalence: A Novel Approach To Developing Complex Generic Dosage Forms
- Cell Counting Is Growing More Important Amid Advanced Therapy’s Rise
- A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine
- AI Is Unearthing New Drug Candidates, But It Still Needs Human Oversight
- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
FEATURED APPLICATION CONTENT
-
Explore strategies for accommodating the ever-increasing upstream titers and volumes to prevent downstream purification from becoming a bottleneck.
-
Discover a process that can be modified to fit your downstream process and serves as a complete solution for concentration and diafiltration.
-
Discover the ability of a novel HEK293 suspension cell line for efficient and scalable rAAV production across various serotypes with low encapsidated host cell DNA levels.
-
Gain insights and guidelines for developing new processes in this review evaluating publications on the applications of single-use, scalable fixed-bed bioreactors for adherent cell culture processes.
-
Here, we outline a scalable and robust upstream process developed for LVV production of HEK293T cells and demonstrate how to expand HEK293T suspension cells.
-
Explore the advantages of utilizing a xeno- and serum-free medium for the targeted expansion of cell subpopulations without the addition of serum.
-
Bulk filling drug substances in traditional facilities is often a lengthy, manual process where operators are relied upon to adjust pump controls to achieve accurate filling. This method, spanning multiple shifts, increases process risk through errors that can compromise accuracy.
-
Learn about a more human-relevant platform that enables researchers to assess the trafficking and killing efficiency of immunotherapy as well as the proof-of-concept of immuno-oncology co-therapy.
-
This study aimed to identify the optimal cell culture conditions to yield high cell density and maintain high cell viability with consistent aggregate morphology and pluripotency marker expression.
-
A promising class of engineered T-cell engaging bispecific antibodies (TCBs) is revolutionizing cancer treatment, but safety concerns persist. Organs-on-Chips offer a human-relevant solution.
-
Examine how Organ-on-a-Chip technology, accurately mimicking human neuroinflammation, offers promising human-relevant avenues for neurodegenerative disease research and therapeutic development.
-
See how the Colon Intestine-Chip has been employed to model cytokine-mediated inflammation and barrier disruption in the intestine.
FEATURED NEWS HEADLINES
- University Of California, Irvine, Verifies GATC Health's Ability To Predict Drug Efficacy, Safety And Off-Target Effects
- Parallel Bio Launches Clinical Trial In A Dish To Speed Drug Discovery
- Sartorius To Advance Drug Discovery And Manufacturing With AI In Collaboration With NVIDIA
- XtalPi To Host Inaugural Symposium On The Acceleration Of Drug Discovery Through The Use Of AI, Automation, And Digitalization
- Novel Inhibitor Insights Offer Pathway To Preventing PXR-Associated Drug Resistance
- A New Drug Shows Potential Benefits In The Recovery Of Patients After A Heart Attack
- CENTOGENE And Evotec Discover Promising New Molecule To Treat Gaucher Disease
- Sumitomo Pharma Announces FDA Acceptance Of Supplemental New Drug Application For Vibegron In Men With Overactive Bladder Symptoms Receiving Pharmacological Therapy For Benign Prostatic Hyperplasia
- Ajax Therapeutics Announces FDA Clearance Of IND Application For AJ1-11095, A First-In-Class Type II JAK2 Inhibitor, For The Treatment Of Myelofibrosis
- Certara & Cloudscientific Accelerate AI For Drug Development In China
ARCHIVED NEWSLETTER
- 05.21.24 -- Bucking Convention: How Analog Ibogaine Could Help Conquer CNS Disorders
- 05.15.24 -- Let's deviate from deviations - Sterile drugs.
- 05.14.24 -- AI Is Unearthing New Drug Candidates, But It Still Needs Human Oversight
- 05.09.24 -- Learn How To Reduce Translational Failure Through Next Generation Organ-on-a-Chip Technology
- 05.07.24 -- AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance